Menu

Recent Interviews

Justin Reid, President and CEO, Troilus Gold Corp.

Justin Reid
President and CEO | Troilus Gold Corp.
36 Lombard Street, Floor 4, M5C 2X3 Toronto, Ontario (CAN)

info@troilusgold.com

+1 (647) 276-0050

Interview Troilus Gold: "We are convinced that Troilus is more than just a mine".


John Jeffrey, CEO, Saturn Oil + Gas Inc.

John Jeffrey
CEO | Saturn Oil + Gas Inc.
Suite 1000 - 207 9 Ave SW, T2P 1K3 Calgary (CAN)

info@saturnoil.com

+1-587-392-7900

Saturn Oil + Gas CEO John Jeffrey: "Acquisition has increased production by 2,000%"


Gary Cope, President and CEO, Barsele Minerals

Gary Cope
President and CEO | Barsele Minerals
Suite 1130 - 1055 W. Hastings Street, V6E 2E9 Vancouver (CAN)

info@barseleminerals.com

+1(604) 687-8566

Interview Barsele Minerals: 'I have never seen a project with such good general conditions'.


01. October 2020 | 13:25 CET

BioNTech, NEL ASA, BYD: Which shares will rise afterward?

  • Investments
Photo credits: pixabay.com

In international comparison, BioNTech is one of the leading pharmaceutical companies in the fight against corona. The research team is receiving substantial funding and support from investors and government agencies for the development of a vaccine against Covid-19. NEL ASA is one of the pioneers in the hydrogen sector and is involved in the development of plant infrastructure for multiple projects. BYD is a company from China that trades as a future competitor of Tesla in investor circles. All companies have proven to be successful. Their share prices have reflected this success having multiplied drastically this year. This has resulted in several billion Euro market valuations. Once a vaccine against Covid-19 becomes available, one industry will benefit particularly and it offers an excellent entry scenario for investors.

time to read: 2 minutes by Mario Hose
ISIN: NL0000235190 , US0970231058 , CA2446331035


 

Author

Mario Hose

Born and raised in Hannover, Lower Saxony follows social and economic developments around the globe. As a passionate entrepreneur and columnist he explains and compares the most diverse business models as well as markets for interested stock traders.

About the author


Total deceleration of everyday life

The spread of Covid-19 has brought many areas of everyday life to a standstill. During the particularly severe restrictions from March to May 2020, the streets were empty and air traffic significantly less. During this time, most people only bought their essentials. People felt vulnerable and restricted their consumption in fear of the unknown - or were forced to out of lack of choice.

Vaccinations are being prepared

Due to the efforts being made by biotechnology companies such as BioNTech, CureVac, and Sanofi to bring a vaccine against Covid-19 to market maturity, it is expected that vaccinations can be started in the first quarter of 2021 at the latest. As BioNTech alone is aiming for a production volume of up to one billion vaccine doses per year, it can be assumed that by 2022 at the latest all people - who so desire - will have been vaccinated.

Vaccination record as a voluntary mandatory document

Once a vaccine against COVID-19 is available, politics and the economy can begin returning to normal. Those who are vaccinated are likely to gain more freedom than those who reject its use due to the obvious risk with non-vaccine takers. When entering a function or boarding a plane, people may in the future not only be asked for their identity card but also their vaccination record. Judging by past events this year, nothing can be ruled out and everything is possible.

Trading houses position themselves for a price increase

The experts from Citigroup and Goldman Sachs have announced their assessment of a winner of the Post Covid-19 period. This is an area that has been pushed aside and avoided by the capital market in recent months. The time has now come for industry experts and investors to position themselves for what is to come.

Be greedy when others are afraid

The analysts of the two financial institutions assume that the overcapacity of crude oil will be used up in 2021 and that the price per barrel will rise again to USD 60.00 or higher. The shares of oil companies are currently still at rock bottom and are attracting little attention. Now is a good time to consider buying shares of producers that are positioned in a legally secure space and prioritise environmental protection. It is important that the company was profitable and had low production costs before the Covid-19 pandemic.

Positive analyst opinion

The Canadian oil producer Saturn Oil & Gas is one such company. During 2019, the company was profitable and was able to report attractive growth rates in revenues. CEO John Jeffrey has already announced that the company will be looking at acquisitions to benefit from the current situation. In recent months, the situation has been correspondingly quiet. Investors in Saturn Oil & Gas may therefore benefit twice over. At CAD 0.10, the currently unheeded share is still trading well below the price of CAD 0.30 two years ago. In the period before Covid-19, the analysts of GBC Research gave a target price of 0.31 CAD in their buy recommendation - this would result in a highly attractive return.


Author

Mario Hose

Born and raised in Hannover, Lower Saxony follows social and economic developments around the globe. As a passionate entrepreneur and columnist he explains and compares the most diverse business models as well as markets for interested stock traders.

About the author



Conflict of interest & risk note

In accordance with §34b WpHG we would like to point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH may hold long or short positions in the aforementioned companies and that there may therefore be a conflict of interest. Apaton Finance GmbH may have a paid contractual relationship with the company, which is reported on in the context of the Apaton Finance GmbH Internet offer as well as in the social media, on partner sites or in e-mail messages. Further details can be found in our Conflict of Interest & Risk Disclosure.


Related comments:

29. July 2021 | 13:56 CET | by André Will-Laudien

Alibaba, Memiontec, MorphoSys - Now the rally after the sell-off!

  • Investments

The regulator's pressure is getting bigger and bigger. China has tightened the thumbscrews on technology giants and especially their online education companies - triggering a stock market quake on its own stock market. In some cases, well-known tech stocks lost double digits, even though the affected areas only affect fractions of annual sales. Government regulation of the USD 100 billion-plus education market is likely to weaken confidence in China's stock markets for the long term. And the fact that China's trade relations with the US have also reached a low point does not make things any better. Are there still opportunities?

Read

28. July 2021 | 10:14 CET | by Nico Popp

Barrick Gold, Mineworx, TUI: Summertime is investment time

  • Investments

Invest or consume? Given the difficult months many of us have had, it would be understandable to unwind now: sun, beach and sea beckon despite rising numbers. But it may also make sense to think more long-term in the face of rapid change. Central banks are allowing more inflation and the printing press continues to run fast. Especially in the current summer lethargy, this can be an opportunity for people with foresight.

Read

26. July 2021 | 12:18 CET | by Stefan Feulner

Twitter, wallstreet:online, Snap - Rally or Crash?

  • Investments

What is next for the global stock markets? Several experts are already passing around price targets of 20,000 points for the DAX due to a lack of investment alternatives. At the same time, the bear camp sees the bursting of the bubble, which was created by the massive financial injections of the FED, coming our way as early as this summer and predicts a crash of unimagined proportions.

Read